Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$2.60 USD
-0.04 (-1.52%)
Updated May 22, 2024 10:39 AM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Ayr Wellness Inc. [AYRWF]
Reports for Purchase
Showing records 21 - 40 ( 90 total )
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: Valuation Expectations Framework
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: Monumental ReScheduling Signals U.S. Cannabis Normalization
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: 2Q23 Takeaways, Ops Right-sizing + Efficiencies Offset Pricing
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
2Q23 Margin Gains with Expansion in 2H23 to Drive OCF
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
1Q23 Solid, Ops Progress Leading to Margin Expansion OCF
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Earnings Week II
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Amends Two Earn-Out Agreements, Alleviates NT Overhang Balance Sheet
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: April 2023 Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: 1Q23 Cannabis Performance, Sales, and Valuation
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
35th Annual Roth Conference Health & Wellness Takeaways
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
4Q22 Margin Expansion, Optimization Internalization with +OCF, PT to $4
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
4Q22 Preview, Execution Focus to Fully Optimize Assets
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S